Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine. (Q51510849)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 January 2011

Language	Label	Description	Also known as
English	Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.	scientific article published on 29 January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Clemens Decristoforo

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

author name string

Alexander Kroiss

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Daniel Putzer

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Christian Uprimny

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Michael Gabriel

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Wolfram Santner

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Christof Kranewitter

7

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Boris Warwitz

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Dietmar Waitz

9

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Dorota Kendler

10

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Irene Johanna Virgolini

11

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

publication date

29 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

number of pages

9

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

38

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

865-873

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Imaging of pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

A fully automated synthesis for the preparation of 68Ga-labelled peptides.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

The new EANM paediatric dosage card

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Nuclear imaging of neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Neuroblastoma and other neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1720-X

21 January 2018

Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear medicine imaging of pheochromocytoma and neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrated Imaging Using MRI and 123| Metaiodobenzylguanidine Scintigraphy to Improve Sensitivity and Specificity in the Diagnosis of Pediatric Neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroblastoma: a disease requiring a multitude of imaging studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Procedure guidelines for MIBG-scintigraphy in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of radioiodinated MIBG for neural crest tumors in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined111In-pentetreotide scintigraphy and123I-mIBG scintigraphy in neuroblastoma provides prognostic information

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole-body MRI of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21279352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-010-1720-X

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21279352

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51510849&oldid=2210874126"